Department of Vascular and Endovascular Surgery, University Hospital of South Manchester, Manchester, UK.
Department of Medical Statistics, University Hospital of South Manchester, Manchester, UK.
Int J Surg. 2017 May;41:91-96. doi: 10.1016/j.ijsu.2017.03.057. Epub 2017 Mar 23.
Surgical lower extremity revascularisation (LER) can lead to poor outcomes that include delayed hospital discharge, in-hospital mortality, major amputations and readmissions. The aim of this study was to identify pre-operative predictors associated with these poor clinical outcomes.
All patients (n = 635; mean age 69; male 67.4%) who underwent surgical LER over a 5 year period in a single tertiary vascular institution were identified. Patients considered to have suffered a poor outcome (Group A) included all in-hospital mortality and major amputations, delayed discharges with a length of stay (LOS) over one standard deviation above the mean or any readmission under any specialty within 12 months. Group A included 247 patients (38.9%) and the good outcome group included the remaining 388 patients (61.1%) from which a sample of 99 patients were selected as controls (Group B).
Mean LOS for the entire study group was 14.4 ± 17.5 days, 12 month readmission rate was 29.1% and in-hospital mortality and major amputation rate was 2.7% and 1.4%, respectively. Pre-admission residence other than own home (OR 9.0; 95% CI 1.2-70.1; P = 0.036), atherosclerotic disease burden (OR 2.2; 95% CI 1.3-3.8; P = 0.003) and tissue loss (OR 3.0; 95% CI 1.6-5.3; P < 0.001) were identified as independent, statistically significant pre-operative predictors of poor outcome. Following discharge, group B patients had a significantly higher rate of amputation free survival and graft infection free survival (P < 0.001) compared to group A.
Recognition of pre-operative predictors of poor outcome should inform case selection and identify high risk patients requiring intensive perioperative optimisation and post discharge follow up.
下肢血管重建术(LER)可能导致不良预后,包括延迟出院、院内死亡、大截肢和再入院。本研究旨在确定与这些不良临床结局相关的术前预测因素。
在一家三级血管专科机构的 5 年内,共确定了 635 例接受手术 LER 的患者(平均年龄 69 岁,男性占 67.4%)。认为预后不良的患者(A 组)包括所有院内死亡和大截肢患者、住院时间超过平均水平 1 个标准差的延迟出院患者,或任何专科在 12 个月内的再入院患者。A 组包括 247 例患者(38.9%),其余 388 例患者(61.1%)为预后良好组,从中选择 99 例患者作为对照组(B 组)。
整个研究组的平均住院时间为 14.4 ± 17.5 天,12 个月的再入院率为 29.1%,院内死亡率和大截肢率分别为 2.7%和 1.4%。术前非自有住所(OR 9.0;95%CI 1.2-70.1;P=0.036)、动脉粥样硬化疾病负担(OR 2.2;95%CI 1.3-3.8;P=0.003)和组织缺失(OR 3.0;95%CI 1.6-5.3;P<0.001)是预后不良的独立、统计学显著的术前预测因素。出院后,B 组患者的无截肢生存率和无移植物感染生存率明显高于 A 组(P<0.001)。
识别预后不良的术前预测因素有助于选择病例,并识别需要强化围手术期优化和出院后随访的高危患者。